Skip to content
My WebMD Sign In, Sign Up

Women's Health

Font Size

Breast Cancer Chemo Drug Ixempra OK'd

FDA Approves Ixempra for Advanced Breast Cancer Chemotherapy
By
WebMD Health News

Oct. 17, 2007 -- The FDA has approved a new breast cancer chemotherapy drug called Ixempra for the treatment of advanced breast cancer.

Bristol-Myers Squibb Co., which makes Ixempra, announced the drug's approval in a news release.

Ixempra will be available "within days," states Bristol-Myers Squibb.

The drug company says Ixempra was approved for patients with metastatic or locally advanced breast cancer whose tumors don't respond to other breast cancer chemotherapy drugs.

Ixempra may be used alone or in combination with the chemotherapy drug Xeloda.

According to Bristol-Myers Squibb, the FDA approved Ixempra based on two studies that included nearly 880 patients with advanced beast cancer.

The most common adverse events in those studies included pain, fatigue, nausea, vomiting, and diarrhea.

Bristol-Myers Squibb recommends caution in using Ixempra in patients with a history of heart disease.

Bristol-Myers Squibb also notes that Ixempra shouldn't be used during pregnancy, and it shouldn't be used with Xeloda in patients with liver problems.

Today on WebMD

woman looking in mirror
Article
Woman resting on fitness ball
Evaluator
 
woman collapsed over laundry
Quiz
Public restroom door sign
Slideshow
 
Couple with troubles
Article
Bone density illustration
VIDEO
 
Young woman being vaccinated
Slideshow
woman holding hand to ear
Slideshow
 
Blood pressure check
Slideshow
mother and daughter talking
Evaluator
 
intimate couple
Article
puppy eating
Slideshow